Sort   by:  
 Page size 
UnknownMaraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
Not available
S-EPMC3828227 | biostudies-literature
UnknownSerum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study.
Not available
S-EPMC11907231 | biostudies-literature
UnknownSwitch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.
Not available
S-EPMC5697828 | biostudies-literature
UnknownEffectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study.
Not available
S-EPMC7289135 | biostudies-literature
UnknownPrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection.
Not available
S-EPMC5519091 | biostudies-literature
UnknownImplementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME project.
Not available
S-EPMC12546834 | biostudies-literature
UnknownTargeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.
Not available
S-EPMC4811324 | biostudies-literature
UnknownPhylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020.
Not available
S-EPMC8986836 | biostudies-literature
Sort   by:  
 Page size